Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu 31-130 vs olanzapine in schizophrenia (12-week randomized double-blind trial)
2008-000479-11Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zicronapine in schizophrenia (2 arms), sponsored by Lundbeck. Primary endpoint: Change in PANSS total score at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
zicronapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-000479-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000479-11.